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848-6 Aortic Valve Calcification and C-Reactive Protein 
Contribute Independently to Coronary Heart Disease 
Incidence
Bobak Salami, Dave Shavelle, Min Xiang, Laurie LaBree, Stanley Azen, Miwa Kawakubo, 
Agnes Papa, Kevin O'Brien, Robert Detrano, Harbor-UCLA Research & Education 
Institue, Torrance, CA, University of Southern California, Los Angeles, CA
Background:
Recent studies suggest that inflammation and aortic valve calcium (AVC) play a role in
the pathogenesis of subsequent cardiovascular events. We sought to determine whether
C-reactive protein (CRP) and AVC are associated with events.
Methods:
858 non-diabetic participants in the South Bay Heart Watch without underlying coronary
heart disease underwent baseline risk factor screening (including CRP levels) and non
contrast gated computed tomography for AVC. Abnormal AVC was defined as > 75th per-
centile of the non zero values (>140 score units) and was present in 41 participants
(4.8%). Mean follow-up was 7.0 +/- 0.5 years. AVC was measured using the method of
the MESA study. Abnormal CRP was defined as > 75th percentile (>3.97 mg/L). Out-
comes of non-fatal myocardial infarction, coronary death, coronary revascularization, or
stroke were considered. Cox regression analysis was performed to determine the effect
of AVC and CRP on clinical outcomes.
Results:
Results are shown in the table. Participants with both elevated AVC and CRP were more
likely to suffer subsequent events than participants with only one of these findings
(P=0.0004).
Conclusion:
A high AVC score in combination with elevated CRP in an asymptomatic person portends
a higher risk for future cardiovascular events than either high AVC or CRP alone.
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1159-183 Circulating T Cell Perturbation and Macrophage 
Activation in Stable Coronary Artery Disease Patients: 
Effect of Atorvastatin Therapy
Hannes F. Alber, Jakob Dörler, Matthias Frick, Wolfgang Dichtl, Ralf-Harun Zwick, Otmar 
Pachinger, Franz Weidinger, University Clinic of Innsbruck, Innsbruck, Austria
Background: 
Coronary artery disease (CAD) is characterized by both T lymphocyte and macrophage
activation. Statins have anti-inflammatory effects beyond lipid lowering. Whether these
also affect the global immune system is unclear. The aim of this study was to investigate
the influence of atorvastatin (atv) on circulating inflammatory T helper lymphocytes
(TH1), on their circulating activation marker soluble CD40 ligand (sCD40L), on the solu-
ble intercellular adhesion molecule-1 (sICAM-1), involved in lymphocyte recruitment and
on neopterin, a macrophage activation marker.
Methods: 
30 hypercholesterolemic patients with angiographically documented stable CAD were
randomized in a double-blind study to placebo or atv (20mg/d) for 3 months. Eight healthy
volunteers served as controls. sCD40L, sICAM-1, neopterin and C-reactive protein
(CRP) levels were measured with ELISA. TH1 and anti-inflammatory T helper (TH2) lym-
phocytes were characterized by intracellular staining of interleukin-2, specific for TH1,
and interleukin-4, specific for TH2 cells, by FACS analysis.
Results: 
TH1 cells (47.9±10.8 vs 31.5±10.5%, p<0.002), neopterin (7.0±2.5 vs 4.5±1.3nmol/L,
p<0.002), sCD40L (10.4± 4.5 vs 6.6±1.6ng/mL, p<0.01), sICAM-1 (251.8±83.6 vs 127.9±
58.7mg/dL, p<0.001) and CRP levels (0.47±0.40 vs 0.07±0.05mg/dL, p<0.001) were
increased in CAD patients compared to controls. TH2 cells were not different. LDL cho-
lesterol was reduced by 37.3±16.5% in atv-treated patients (p<0.001) and by 8.2±15.7%
(p=0.041) in the placebo group. TH1 and TH2 lymphocytes did not change in both groups.
By contrast, neopterin (p<0.02), sCD40L (p<0.02), sICAM-1 (p<0.01) and CRP (p<0.01)
were decreased in the atv group, but remained similar in the placebo group.
Conclusion: 
Our data suggest that a systemic immune activation is present also in stable CAD
patients. This activation is partially abolished by atorvastatin, supporting anti-inflamma-
tory properties of this agent.
1159-184 Maternal Undernutrition and Early Postnatal Diet Affect 
Aortic Structure and Composition in Rats
Michael R. Skilton, Lisa M. Ho, Alison K. Gosby, Ian D. Caterson, David S. Celermajer, 
University of Sydney, Sydney, Australia
Many epidemiologic studies suggest a link between fetal and early infant nutrition, and
predisposition to adult hypertension and coronary artery disease. We therefore examined
the effects of altering nutrition during gestation, lactation, and then throughout juvenile
life, on aortic structure and composition in rats.
Wistar rat dams were fed either a control (20% protein, 4% fat) or low protein (8% protein,
4% fat; LP) diet throughout pregnancy, or a low protein diet for the final 7 days of gesta-
tion only (LLP – last trimester low protein diet). At 21 days post-partum, 56 male pups
were weaned onto a control, LP or high fat diet (20% protein, 25% fat). All diets were iso-
caloric. At 12 weeks, rats were euthanased, the thoracic aorta perfusion fixed in situ and
then harvested. Aortic sections (6um thick) were stained with resorcin-fuchsin, to assess
elastin content. Media thickness, lumen diameter and elastin content were measured
using NIH Image software (blinded analysis).
Rats belonging to the maternal LP group had significantly reduced aortic lumen size
(1.80 ± 0.03 vs 2.03 ± 0.05mm) and media thickness (128 ± 4 vs 143 ± 4um), when com-
pared with controls (p<0.01). The maternal LLP group exhibited an increased percentage
of elastin in the aortic wall (66 ± 1 vs 62 ± 1%, p<0.05) when compared with controls,
while media thickness (137 ± 6um) and lumen diameter (2.10 ± 0.19mm) were unaf-
fected. Regarding the effect of post-natal diet, low protein was associated with a further
significant reduction in media thickness (p<0.05), but no change in lumen size or wall
composition. A high fat diet after birth did not affect aortic parameters.
In conclusion, protein restriction throughout gestation results in significant reductions in
aortic wall thickness and lumen size, exacerbated further by protein restriction after birth.
These changes may contribute to the observed association between undernutrition in
fetal/early life and vascular disease in adults.
1159-185 Smoking-Related Endothelial Dysfunction and 
Increased Serum Levels of Proinflammatory Cytokines 
and Adhesion Molecules Are Reversible by Antioxidant 
Treatment
Charalambos Antoniadis, Dimitrios Tousoulis, Marina Toutouza, Costas Tentolouris, 
Carmen Vasiliadou, Kyriakoula Marinou, Costas Tsioufis, Emmanuel Vavuranakis, 
Christos Pitsavos, Christodoulos Stefanadis, Athens Univeristy Medical School, Athens, 
Greece
Introduction: Smoking-related endothelial dysfunction and increased levels of interleuk-
ines 1b (IL-1b) and 6 (IL-6), tumor necrosis factor alpha (TNF-a), vascular cell adhesion
molecule (sVCAM-1), intercellular adhesion molecule (sICAM-1) and lipid hydroperox-
ides (LPO), are implicated in atherogenesis. The effect of combined administration of
vitamins C and E on endothelial function, lipid peroxidation and inflammatory process in
smokers is unknown.
Methods: Forty-two healthy smokers (aged 36±2 yrs old) received vitamin C 2g/d (n=10,
VITC), vitamin C 2g/d plus vitamin E 400IU/d (n=11, VITCE400), vitamin C 2g/d plus vita-
min E 800IU/day (n=10, VITCE800) or no treatment (n=11, Controls), for 4 weeks. Fore-
arm blood flow was measured using venous occlusion strain gauge plethysmography.
Endothelium dependent dilation (EDD) and endothelium independent dilation were
expressed as the %change of flow from rest to the maximum flow during reactive hypere-
mia or after sublingual nitroglycerine administration respectively. Inflammatory markers
were determined with ELISA and LPO spectrocolorimetrically.
Results: EDD was increased in VITCE400 (46.5±5.4 to 74.3±9.2%, p<0.01) and
VITCE800 (43.6±3.9 to 74.9±4.2%, p<0.001), but not in VITC and control groups. Simi-
larly, LPO was reduced in VITCE400 and VITCE800 groups (14.5±1.2 and 15.4±2.9 to
8.8±1.6 and 8.3±1.7 µM respectively, p<0.05 for both) only. However, in VITCE800, a sig-
nificant decrease was observed in levels of IL-1b (0.31±0.07 to 0.10±0.02 pg/ml, p<0.05),
IL-6 (4.69±0.90 to 2.02±0.71 pg/ml,p<0.05), sVCAM-1 (339±14 to 298±11 ng/ml, p<0.05)
and sICAM-1 (318±21 to 250±19 ng/ml, p<0.05), while TNF-a levels were slightly but not
significantly decreased (1.76±0.343 to 1.27±0.074 pg/ml, p=NS). All the above parame-
ters remained unchanged in VITC, VITCE400 and control groups.
Conclusions: Combined treatment with vitamins C (2g/day) and E (400 or 800IU/day),
decreased lipid peroxidation and improved endothelial function in smokers. Combined
administration of vitamins C (2g/d) and E (800IU/d) also decreased levels of IL-1b, IL-6,
sVCAM-1 and sICAM-1 in these subjects.
1159-186 High- but Not Low-Dose Folic Acid Improves 
Endothelial Function in Coronary Artery Disease
Anil K. Madhavan, Stuart J. Moat, Ian F. McDowell, Malcolm J. Lewis, Jonathan 
Goodfellow, Derek Lang, Wales Heart Research Institute, Cardiff, United Kingdom
Background: Previous studies have demonstrated that high dose folic acid can improve
endothelial function in coronary artery disease (CAD). However, the most efficacious
dose of folic acid and the significance of homocysteine-lowering remain unclear. There-
fore we sought to investigate the effects of both high dose (5mg/day) and low dose
(400µg/day) folic acid supplementation on homocysteine-lowering and endothelial func-
tion in CAD.
Methods: 75 CAD patients entered a randomised, double blind, placebo controlled study
comprising 3 parallel treatment groups (placebo, high and low dose folic acid). Endothe-
lial function, assessed by flow-mediated dilatation (FMD) of the brachial artery, was mea-
sured before and after 6 weeks treatment. Plasma folate, B12, total homocysteine, lipid
profile, glucose and creatinine were also measured before and after treatment. All data
are expressed as mean ± standard deviation.
Results: No significant changes in any parameters were observed in the placebo treated
group. Treatment with high dose and low dose folic acid significantly (p<0.001) increased
CRP-, AVC- CRP-, AVC+ CRP+,
AVC-
CRP+,
AVC+
RR 1.0 1.63 1.32 4.28
95% CI --- 0.70-3.79 0.86-2.02 1.92-9.57
P --- 0.26 0.21 0.0004
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plasma folate (8.9±3.8 to 34.3±16.5µg/l & 9.9±4.1 to 17.4±7.6µg/l respectively; ∆ high c.f.
low dose p<0.001). Both doses of folic acid significantly (p<0.001) lowered plasma total
homocysteine (12.9±5.6 to 9.9±2.6µmol/l for high dose & 11.7±3.1 to 10.5±1.8µmol/l for
low dose; ∆ high c.f. low dose p=0.219). However, FMD was improved only following high
(99±35 c.f. 24±26µm pretreatment, p<0.001) and not low (42±32 c.f. 26±59µm pretreat-
ment, p=0.264) dose folic acid. No differences between groups were evident for any of
the other parameters measured.
Conclusion: The data demonstrate that high but not low dose folic acid improves endot-
helial function in CAD despite a significant reduction in homocysteine in both treatment
groups. This suggests that the beneficial effects of folic acid on endothelial function occur
via a mechanism that is independent of homocysteine-lowering. These results have
important implications for the current clinical trials of folic acid supplementation using low
dose folic acid.
1159-187 Long-Term Use of Pioglitazone Slows Arteriosclerotic 
Progression in Type 2 Diabetics
Tatsuaki Murakami, Masateru Ohnaka, Fukui Cardiovascular Center, Fukui, Japan
Introduction and hypothesis: Insulin resistance is thought to be highly involved in arte-
riosclerotic processes, but the long-term effects of insulin sensitizing agents remain
unknown. We assessed hypothesis that long-term use of pioglitazone, an insulin sensi-
tizer, slows ultrasonic manifestation of atherosclerosis.
Methods: Thirty type-2 diabetic patients with suspected coronary artery disease were
randomized to group-P where they received pioglitazone (30mg per day) for more than 1
year, or to group-C where they continued therapy without thiazolidinedione for more than
1 year. We noninvasively ultrasonic quantified flow mediated dilation of brachial artery
after 5 minutes forearm occlusion (FMD) and we also quantified arterial stiffness by bra-
chial-to-ankle pulse wave velocity (PWV). Changes in FMD and PWV from the baseline
through the follow-up point were compared between the 2 groups. Results: Group-P
(n=15) manifested good compliance to the treatment and improvements in insulin resis-
tant variables represented by HOMA-IR while group-C showed no improvement. FMD
was improved after medication in group-P (p<0.01) but not in group-C (p=ns). PWV
decreased in group-P (p=0.02) but increased in group-C (p=0.03). 
Conclusion: In conclusion long-term pioglitazone use improves endothelial function and
arterial wall compliance, which may have beneficial potentials for management of arterio-
sclerosis in type-2 diabetics.
1159-188 Grape Seed and Skin Extracts Alter Platelet Function 
and Release of Reactive Oxygen Species
Olga Vitseva, Sonia Varghese, Subrata Chakrabati, John Folts, Jane E. Freedman, 
Boston University School of Medicine, Boston, MA
Background: Moderate red wine consumption is inversely associated with coronary
ischemia. Red wine and purple grape juice (PGJ) contain polymeric flavonoids with anti-
oxidant properties believed to be protective against cardiovascular events. Acute cardiac
events are also associated with decreased platelet-derived nitric oxide (NO) release. In
this study, the effects of extracts from grape skins or seeds on platelet function, NO, and
superoxide release were determined.
Methods and Results: Incubation of platelets with seed (100 mg/L) or skin (250 mg/L)
extract led a decrease in platelet aggregation of 65% ± 7% and 49% ± 9%, respectively
(n=6; P<0.001). Grape seed or skin extract increased platelet-derived NO release by
126% ± 19% and 92% ± 20%, respectively (n=5, P<0.001). Platelet incubation with
extracts led to a marked decrease in superoxide release from 73 ± 6 to 2 ± 3 for grape
seeds and to 7.3 ± 6.4 for grape skin (arb. Chemilum. units; n=5, P<0.0001). These
effects were dose-dependent for both grape extracts. Coincubation with seeds and skins
led to additive effect on inhibition of platelet aggregation, enhanced NO release, and
ablated superoxide production, but did not significantly alter release of aggregation
induced soluble CD40 ligand, a marker of inflammatory-thrombotic interactions.
Conclusion: The skins and seeds from grapes inhibit platelet function and increase bio-
active NO. These effects may be due to the markedly decreased release of superoxide
anion or via another antioxidant-sparing mechanism. Red wine has been shown to
enhance vascular function via a NO-dependent mechanism and the extracts derived from
grapes appear to provide similar beneficial properties.
1159-189 Echocardiographic Correlates of Pulmonary 
Hypertension in 2,337 Patients
James N. Mohn, Richard W. Asinger, Charles A. Herzog, Bradley A. Bart, Hennepin 
County Medical Center, Minneapolis, MN
Background: Echocardiographic findings in a large population of unselected patients
with pulmonary hypertension (PH) have not been reported, and are herein described.
Methods: Using our echocardiographic database, we retrospectively identified all adult
patients having measurable tricuspid regurgitation (n=14,869). Patients with estimated
RV-RA gradients _ 40 mmHg were defined as having PH (n=2,337); those having gradi-
ents _ 20 were defined as having no PH (n=3,136). Demographic information, clinical
data and codified echocardiographic findings were analyzed for their association with PH.
Differences between cohorts were assessed using the t-test and chi square test for con-
tinuous and dichotomous variables, respectively.
Results: The PH cohort was significantly older (64.3±16.9 yrs vs. 47.1 ± 17.7 yrs) and
had a small but significant male preponderance (50.3% vs. 45.2%). Body mass index
(BMI) was significantly greater in the PH group (30.2 ± 10.2 vs. 27.3± 7.3), and grouped
analyses of echocardiographic parameters are presented below.
Conclusion: PH was present in over 15% of patients with measurable tricuspid regurgi-
tation. Compared to patients without PH, there are striking differences in age, sex, weight
and measures of atrial, LV, RV and valvular morphology and function. A significant num-
ber of PH patients (25.3%) lacked left-sided pathology that could contribute to the pres-
ence of PH. To our knowledge, this study represents the largest cohort of unselected PH
patients described. 
1159-190 Role of the 807 C/T Polymorphism of Glycoprotein Ia/IIa 
on Platelet Function Following Clopidogrel Loading 
Dose in Patients Undergoing Coronary Stenting
Dominick J. Angiolillo, Antonio Fernández-Ortiz, Esther Bernardo, Celia Ramirez, 
Elisabetta Trabetti, Chiara Stranieri, Manel Sabate, Fernando Alfonso, Pierfranco 
Pignatti, Carlos Macaya, San Carlos University Hospital, Madrid, Spain, Univeristy of 
Verona, Verona, Italy
Background: The 807 C/T polymorphism of the glycoprotein (GP) Ia/IIa is the major
platelet-collagen receptor. In particular, T allele carriers have increased receptor density
and thrombotic risk. Aim of the study was to assess the role of the 807 C/T polymorphism
on platelet aggregation (PA) following a 300 mg clopidogrel loading dose (LD) after coro-
nary stenting (CS). Methods: The 807 C/T genotype was assessed in 44 patients (P). P
were divided into 2 groups: carriers (CT + TT genotypes) and non-carriers (CC genotype)
of the T allele. All P were on aspirin and those receiving GP IIb/IIIa blockers were not
included. PA (expressed as %) was assessed at baseline (B), and 4hrs and 24hrs follow-
ing LD by light transmittance aggregometry using ADP (6 µM) and collagen (6 µg/mL) as
agonists. Results: There were 32/44 T allele carriers and 12/44 CC homozygotes. ADP-
induced PA did not differ between groups (Table). Following collagen stimuli, PA was
higher (*p<0.05) in T allele carries following LD (Table). PA reduced (#p<0.001) at 4 and
24 hrs in all P except after collagen stimuli in T allele carriers. There were no differences
in fibrinogen and von Willebrand factor levels, platelet count, and clinical status. Conclu-
sions: The T allele of the GP Ia/IIa gene is associated with increased platelet reactivity
and a lower response to clopidogrel LD following collagen stimuli. This suggests that T
allele carriers have a more extensive platelet adherence to fibrillar collagens which may
contribute to their increased thrombotic risk.
1159-191 Effect of a Single High-Fat Meal on Endothelial 
Microparticles as a Marker of Endothelial Injury
Arley A. Peter, Alexandre Ferreira, Salim Virani, Eduardo de Marchena, Santiago Garcia, 
Reyan Ghany, Josh Purow, Joaquim Jimenez, Yeon Ahn, Jackson Memorial Hospital 
University of Miami, Miami, FL
BACKGROUND: This study was designed to evaluate a possible relationship between
levels of CD31+/CD42b- Endothelial Microparticles (EMP), markers of endothelial injury,
and cholesterol levels in healthy volunteers.
METHODS: A total of 23 healthy subjects without any major risk factors or previous car-
diovascular risk factors were evaluated. A fasting cholesterol profile and EMP levels were
measured in all subjects. Endothelial microparticles were measured by flow cytometry
using fluorescent monoclonal antibodies.
RESULTS: Subjects were divided in two different groups according to fasting total cho-
lesterol. Group A had cholesterol levels below 200 mg/dl (157 + 31) and group B had
serum cholesterol equal or greater than 200 mg/dl ( 258.4 + 11.14); p: < 0.0001. The
measured levels of EMP (x10^6/mL) were 0.388824 + 0.053954 in group A and 0.964 +
0.185148589 in group B (P< 0.0001). The 17 subjects in group A were then fed a high fat
meal containing 900calories, 50g of fat, 14g of saturated fat, and 255mg of cholesterol.
The measured levels of EMP (x10^6/mL) fasting, at one hour and three hours were
0.388824 + 0.053954, 0.541176 +0.138649 and 0.676667 +0.158505, respectively.
Baseline
group-P
Follow-up
group-P
Baseline
group-C
Follow-up
group-C
FMD 4.1±1.6% 7.1±2.7% 1727±269cm/s 1664±234cm/s
PWV 4.1±1.8% 4.2±1.7% 1710±232cm/s 1797±215cm/s
Clinical and Echocardiographic 
Findings
Pulmonary 
Hypertension
(n=2,337)
No Pulmonary 
Hypertension
(n=3,136)
p-value
Age in years (mean ± SD) 64.3 ± 16.9 47.1 ± 17.7 <.001
Gender Female (%) 49.7% 54.8% <.001
BMI (Kg/m2 , mean ± SD) 30.2 ± 10.2 27.3 ± 7.3 <.001
Abnormal LV Morphology or Function 69.4% 30.6% <.001
Abnormal RV Morphology or Function 35.9% 11.3% <.001
Abnormal Atrial Morphology or Rhythm 58.0% 23.3% <.001
Moderate or Severe Left Sided Valvular 
Disease
35.0% 7.8% <.001
Pericardial Abnormalities 20.5% 9.5% <.001
Any L-Sided Abnormalities (Valvular, 
Structural or Functional)
74.7% 41.0% <.001
ADP B 4 hrs 24 hrs
CC 61±16 43±13# 32±9#
CT+TT 55±18 42±18# 35±19#
Collagen B 4 hrs 24 hrs
CC 42±15 30±13# 31±14#
CT+TT 47±19 43±21* 46±26*
